| |
|
|
 |
- Address:
- 101 North Wilmot Road, Suite 600
Tucson, AZ 85711
- Phone:
- 520-748-4462
- Website:
- http://www.rctech.com
-
- Company Information:
-
Aeson Therapeutics Inc., is located at Tucson, AZ and is a drug development company developing fluasterone as a treatment forlipid disorders and as a cancer chemoprevention agent.
The company is currently conducting a PhaseIIa randomized, double-blinded, placebo-controlled study examining the efficacy of fluasterone onlowering triglyceride levels in patients with metabolic syndrome.
Fluasterone will be positioned as a safe alternative to fibrates for lowering triglyceride incombination therapy with a statin in insulin-resistant patients with mixed hyperlipidemia.
Dehydroepiandrosterone (DHEA) may have therapeutic uses against cardiovascular disease, immune disorders, cancer and other diseases, but the hormone is a precursor of androgens and estrogens and can cause undesirable side effects.
RCT formed Aeson Therapeutics to develop fluasterone, a synthetic steroid that may be more effective than DHEA without the adverse side effects. Fluasterone development targets include treatment of lipid disorders, inflammatory diseases and as a cancer chemoprevention agent.
|
 |
|
|
